[144] Varonis Systems, Inc. SEC Filing
Notice of Proposed Sale under Rule 144: This Form 144 reports a proposed sale of 56,940 common shares of Varonis Systems, Inc. (VRNS) with an aggregate market value of $3,332,128.80, using Morgan Stanley Smith Barney LLC as broker and an approximate sale date of 08/22/2025. The shares were acquired as Performance Stock Units on 02/29/2024. The filing shows 112,047,109 shares outstanding. The record also lists two 10b5-1 sales by Guy Melamed within the past three months: 42,705 shares sold on 08/13/2025 for $2,465,133.31 and 51,889 shares sold on 08/01/2025 for $2,859,281.08. The filer attests to Rule 10b5-1 representations and confirms no undisclosed material adverse information.
Avviso di vendita proposta ai sensi della Regola 144: Questo Modulo 144 segnala una vendita proposta di 56.940 azioni ordinarie di Varonis Systems, Inc. (VRNS) per un valore di mercato aggregato di $3.332.128,80, tramite Morgan Stanley Smith Barney LLC come broker e una data di vendita approssimativa del 22/08/2025. Le azioni sono state acquisite come Performance Stock Units il 29/02/2024. Il deposito indica 112.047.109 azioni in circolazione. Il record riporta inoltre due vendite secondo il piano 10b5-1 da parte di Guy Melamed negli ultimi tre mesi: 42.705 azioni vendute il 13/08/2025 per $2.465.133,31 e 51.889 azioni vendute il 01/08/2025 per $2.859.281,08. Il dichiarante attesta le dichiarazioni richieste dalla Regola 10b5-1 e conferma l'assenza di informazioni materiali sfavorevoli non divulgate.
Aviso de venta propuesta conforme a la Regla 144: Este Formulario 144 informa una venta propuesta de 56.940 acciones ordinarias de Varonis Systems, Inc. (VRNS) con un valor de mercado agregado de $3.332.128,80, usando a Morgan Stanley Smith Barney LLC como corredor y con una fecha de venta aproximada del 22/08/2025. Las acciones se adquirieron como Performance Stock Units el 29/02/2024. La presentaci贸n muestra 112.047.109 acciones en circulaci贸n. El registro tambi茅n enumera dos ventas bajo 10b5-1 por Guy Melamed en los 煤ltimos tres meses: 42.705 acciones vendidas el 13/08/2025 por $2.465.133,31 y 51.889 acciones vendidas el 01/08/2025 por $2.859.281,08. El presentador afirma las representaciones de la Regla 10b5-1 y confirma que no hay informaci贸n material adversa no divulgada.
攴滌爼 144鞐� 霐半ジ 鞓堨爼 毵る弰 韱奠: 鞚� Form 144電� Morgan Stanley Smith Barney LLC毳� 欷戧皽鞚胳溂搿� 鞚挫毄頃橃棳 雽�霝奠爜鞚� 毵る弰 鞓堨爼鞚检潉 2025-08-22搿� 頃橃棳 Varonis Systems, Inc.(VRNS)鞚� 氤错喌欤� 56,940欤�(齑� 鞁滉皜: $3,332,128.80)鞚� 毵る弰毳� 氤搓碃頃╇媹雼�. 頃措嫻 欤检嫕鞚� 2024-02-29鞐� Performance Stock Units搿� 旆摑霅橃棃鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 鞙犿喌 欤检嫕 靾橁皜 112,047,109欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟. 旮半鞐愲姅 霕愴暅 歆�雮� 3臧滌洈 雮� Guy Melamed鞚� 10b5-1 攴滌爼鞐� 霐半ジ 霊� 瓯挫潣 毵る弰臧� 雮橃檧 鞛堨姷雼堧嫟: 2025-08-13鞐� 42,705欤� 毵る弰(旮堨暋 $2,465,133.31) 氚� 2025-08-01鞐� 51,889欤� 毵る弰(旮堨暋 $2,859,281.08). 鞁犼碃鞚胳潃 攴滌爼 10b5-1 甏�霠� 歆勳垹鞚� 頇曥澑頃橂┌ 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 頇曥暯頃╇媹雼�.
Avis de vente propos茅e en vertu de la r猫gle 144 : Ce formulaire 144 rapporte une vente propos茅e de 56听940 actions ordinaires de Varonis Systems, Inc. (VRNS) pour une valeur marchande agr茅g茅e de 3鈥�332鈥�128,80 $, en utilisant Morgan Stanley Smith Barney LLC comme courtier et une date de vente approximative au 22/08/2025. Les actions ont 茅t茅 acquises en tant que Performance Stock Units le 29/02/2024. le d茅p么t indique 112鈥�047鈥�109 actions en circulation. Le dossier mentionne 茅galement deux ventes 10b5-1 par Guy Melamed au cours des trois derniers mois : 42鈥�705 actions vendues le 13/08/2025 pour 2鈥�465鈥�133,31 $ et 51鈥�889 actions vendues le 01/08/2025 pour 2鈥�859鈥�281,08 $. Le d茅clarant atteste des d茅clarations requises par la r猫gle 10b5-1 et confirme l'absence d'informations d茅favorables importantes non divulgu茅es.
Meldung eines geplanten Verkaufs gem盲脽 Regel 144: Dieses Formular 144 meldet einen geplanten Verkauf von 56.940 Stammaktien der Varonis Systems, Inc. (VRNS) mit einem aggregierten Marktwert von $3.332.128,80, unter Verwendung von Morgan Stanley Smith Barney LLC als Broker und einem ungef盲hren Verkaufstermin am 22.08.2025. Die Aktien wurden als Performance Stock Units am 29.02.2024 erworben. Die Einreichung weist 112.047.109 ausstehende Aktien aus. In den Aufzeichnungen sind zudem zwei 10b5-1-Verk盲ufe von Guy Melamed in den letzten drei Monaten aufgef眉hrt: 42.705 Aktien verkauft am 13.08.2025 蹿眉谤 $2.465.133,31 und 51.889 Aktien verkauft am 01.08.2025 蹿眉谤 $2.859.281,08. Der Einreicher bekr盲ftigt die Angaben gem盲脽 Regel 10b5-1 und best盲tigt, dass keine nicht offenbarten, wesentlichen nachteiligen Informationen vorliegen.
- Acquisition clearly disclosed: Shares were acquired as Performance Stock Units on 02/29/2024.
- Broker specified: Morgan Stanley Smith Barney LLC is named for the proposed transaction.
- Prior 10b5-1 sales disclosed: Two recent 10b5-1 sales (08/01/2025 and 08/13/2025) with gross proceeds are listed, increasing transparency.
- None.
Insights
TL;DR: Routine insider sale notice: 56,940 shares (~$3.33M) proposed for sale; recent 10b5-1 execution activity shown.
The filing is a standard Form 144 disclosure reporting a proposed sale of common stock by an insider or affiliate. Key facts are the share amount, aggregate market value, acquisition as performance stock units on 02/29/2024, and use of Morgan Stanley Smith Barney as broker. The form also documents recent 10b5-1 sale activity for the named seller on 08/01/2025 and 08/13/2025 with stated proceeds. This provides transparency about insider liquidity events but does not, by itself, convey operational or financial performance information about the issuer.
TL;DR: Compliance disclosure appears complete for a Rule 144 notice and references 10b5-1 plan sales; no disclosed material nonpublic information.
The document includes required elements for Rule 144 reporting: class of security, broker, number of shares, market value, outstanding shares, acquisition details, and prior three-month sales records. It states the seller's representation regarding absence of undisclosed material adverse information and references plan adoption/instruction dates related to 10b5-1 activity. The filing reads as a procedural disclosure to satisfy securities-law reporting obligations rather than a material corporate event.
Avviso di vendita proposta ai sensi della Regola 144: Questo Modulo 144 segnala una vendita proposta di 56.940 azioni ordinarie di Varonis Systems, Inc. (VRNS) per un valore di mercato aggregato di $3.332.128,80, tramite Morgan Stanley Smith Barney LLC come broker e una data di vendita approssimativa del 22/08/2025. Le azioni sono state acquisite come Performance Stock Units il 29/02/2024. Il deposito indica 112.047.109 azioni in circolazione. Il record riporta inoltre due vendite secondo il piano 10b5-1 da parte di Guy Melamed negli ultimi tre mesi: 42.705 azioni vendute il 13/08/2025 per $2.465.133,31 e 51.889 azioni vendute il 01/08/2025 per $2.859.281,08. Il dichiarante attesta le dichiarazioni richieste dalla Regola 10b5-1 e conferma l'assenza di informazioni materiali sfavorevoli non divulgate.
Aviso de venta propuesta conforme a la Regla 144: Este Formulario 144 informa una venta propuesta de 56.940 acciones ordinarias de Varonis Systems, Inc. (VRNS) con un valor de mercado agregado de $3.332.128,80, usando a Morgan Stanley Smith Barney LLC como corredor y con una fecha de venta aproximada del 22/08/2025. Las acciones se adquirieron como Performance Stock Units el 29/02/2024. La presentaci贸n muestra 112.047.109 acciones en circulaci贸n. El registro tambi茅n enumera dos ventas bajo 10b5-1 por Guy Melamed en los 煤ltimos tres meses: 42.705 acciones vendidas el 13/08/2025 por $2.465.133,31 y 51.889 acciones vendidas el 01/08/2025 por $2.859.281,08. El presentador afirma las representaciones de la Regla 10b5-1 y confirma que no hay informaci贸n material adversa no divulgada.
攴滌爼 144鞐� 霐半ジ 鞓堨爼 毵る弰 韱奠: 鞚� Form 144電� Morgan Stanley Smith Barney LLC毳� 欷戧皽鞚胳溂搿� 鞚挫毄頃橃棳 雽�霝奠爜鞚� 毵る弰 鞓堨爼鞚检潉 2025-08-22搿� 頃橃棳 Varonis Systems, Inc.(VRNS)鞚� 氤错喌欤� 56,940欤�(齑� 鞁滉皜: $3,332,128.80)鞚� 毵る弰毳� 氤搓碃頃╇媹雼�. 頃措嫻 欤检嫕鞚� 2024-02-29鞐� Performance Stock Units搿� 旆摑霅橃棃鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 鞙犿喌 欤检嫕 靾橁皜 112,047,109欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟. 旮半鞐愲姅 霕愴暅 歆�雮� 3臧滌洈 雮� Guy Melamed鞚� 10b5-1 攴滌爼鞐� 霐半ジ 霊� 瓯挫潣 毵る弰臧� 雮橃檧 鞛堨姷雼堧嫟: 2025-08-13鞐� 42,705欤� 毵る弰(旮堨暋 $2,465,133.31) 氚� 2025-08-01鞐� 51,889欤� 毵る弰(旮堨暋 $2,859,281.08). 鞁犼碃鞚胳潃 攴滌爼 10b5-1 甏�霠� 歆勳垹鞚� 頇曥澑頃橂┌ 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 頇曥暯頃╇媹雼�.
Avis de vente propos茅e en vertu de la r猫gle 144 : Ce formulaire 144 rapporte une vente propos茅e de 56听940 actions ordinaires de Varonis Systems, Inc. (VRNS) pour une valeur marchande agr茅g茅e de 3鈥�332鈥�128,80 $, en utilisant Morgan Stanley Smith Barney LLC comme courtier et une date de vente approximative au 22/08/2025. Les actions ont 茅t茅 acquises en tant que Performance Stock Units le 29/02/2024. le d茅p么t indique 112鈥�047鈥�109 actions en circulation. Le dossier mentionne 茅galement deux ventes 10b5-1 par Guy Melamed au cours des trois derniers mois : 42鈥�705 actions vendues le 13/08/2025 pour 2鈥�465鈥�133,31 $ et 51鈥�889 actions vendues le 01/08/2025 pour 2鈥�859鈥�281,08 $. Le d茅clarant atteste des d茅clarations requises par la r猫gle 10b5-1 et confirme l'absence d'informations d茅favorables importantes non divulgu茅es.
Meldung eines geplanten Verkaufs gem盲脽 Regel 144: Dieses Formular 144 meldet einen geplanten Verkauf von 56.940 Stammaktien der Varonis Systems, Inc. (VRNS) mit einem aggregierten Marktwert von $3.332.128,80, unter Verwendung von Morgan Stanley Smith Barney LLC als Broker und einem ungef盲hren Verkaufstermin am 22.08.2025. Die Aktien wurden als Performance Stock Units am 29.02.2024 erworben. Die Einreichung weist 112.047.109 ausstehende Aktien aus. In den Aufzeichnungen sind zudem zwei 10b5-1-Verk盲ufe von Guy Melamed in den letzten drei Monaten aufgef眉hrt: 42.705 Aktien verkauft am 13.08.2025 蹿眉谤 $2.465.133,31 und 51.889 Aktien verkauft am 01.08.2025 蹿眉谤 $2.859.281,08. Der Einreicher bekr盲ftigt die Angaben gem盲脽 Regel 10b5-1 und best盲tigt, dass keine nicht offenbarten, wesentlichen nachteiligen Informationen vorliegen.
FAQ
What does the Form 144 filed for Varonis (VRNS) report?
Who is the broker handling the proposed VRNS sale?
When and how were the shares to be sold acquired?
Were there recent insider sales reported for VRNS in the past three months?
How many Varonis shares are outstanding according to this filing?
